SLC12A5 and type 2 diabetes mellitus: Women carrying PTVs in SLC12A5 had higher odds of T2D than non-carriers (odds ratio [OR] 17.1 [4.3–67.5], Pglm = 5.2 × 10−5) with four of nine having T2D (UK Biobank T2D prevalence in females = 5.6% [12,675/227,363], PExact = 7.9 × 10−4, Table S5).